CTD T AM 6.25/40/5 10'S

About

CTD T AM 6.25/40/5 is a potent triple-combination medication designed for the comprehensive management of severe or resistant hypertension. It combines three distinct classes of antihypertensive agents: a thiazide-like diuretic (Chlorthalidone), an angiotensin receptor blocker (Telmisartan), and a calcium channel blocker (Amlodipine). Chlorthalidone works by increasing the excretion of sodium and water, reducing blood volume and peripheral resistance. Telmisartan blocks the effects of angiotensin II, a powerful vasoconstrictor, leading to vasodilation and reduced blood pressure. Amlodipine relaxes the smooth muscles in blood vessel walls, further promoting vasodilation. This multi-pronged approach targets various mechanisms involved in blood pressure regulation, providing superior control for patients whose blood pressure is not adequately managed by dual therapy, thereby significantly reducing the risk of cardiovascular morbidity and mortality.

Uses

• Treatment of severe or resistant hypertension.
• Management when dual therapy is insufficient.
• Reduction of cardiovascular risk in high-risk patients.
• Long-term blood pressure control.

Directions For Use

Take one tablet orally once daily, with or without food, at the same time each day, as directed by your physician.

Benefits

• Potent and comprehensive blood pressure reduction.
• Targets multiple pathways for superior control.
• Reduces the risk of major cardiovascular events.
• Convenient once-daily dosing for adherence.
• Effective for resistant hypertension cases.
• Provides sustained antihypertensive action.

Side Effects

• Dizziness or lightheadedness.
• Headache.
• Fatigue or weakness.
• Ankle swelling or edema.
• Orthostatic hypotension.
• Electrolyte imbalances (e.g., low potassium).
• Muscle cramps.
• Dry mouth.
• Increased urination.
• Abdominal pain or nausea.
• Flushing.
• Slow heart rate (bradycardia).

Safety Measures

• Alcohol - Avoid or limit alcohol consumption as it can significantly enhance the blood pressure-lowering effect, leading to increased dizziness and fainting.
• Pregnancy - Contraindicated during pregnancy, especially in the second and third trimesters, due to the ARB component's potential for severe fetal harm.
• Breastfeeding - Not recommended during breastfeeding as components can pass into breast milk and may pose risks to the infant. Consult your doctor.
• Liver - Use with caution in patients with liver impairment, as dose adjustments may be necessary. Monitor liver function regularly.
• Kidney - Dose adjustment is required in patients with kidney impairment. Monitor renal function closely, especially in severe cases, due to the diuretic and ARB components.
• Lung - No specific direct adverse effects on lung conditions are typically associated, but general caution applies for severe underlying respiratory issues.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.